Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Marianne T. Sweetser | Researchclopedia

Back to researchers

Marianne T. Sweetser

Alnylam Pharmaceuticals (United States)

114

Works

12,344

Citations

38

h-index

50

i10-index

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes Porphyrin Metabolism and Disorders Heme Oxygenase-1 and Carbon Monoxide

Affiliations

Université Claude Bernard Lyon 12021–2021

Brigham and Women's Hospital2019–2019

Biogen (United States)2005–2016

Harvard University2019–2019

Alnylam Pharmaceuticals (United States)2015–2025

Top Works

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams,Alejandra González‐Duarte,et al.

20182,836 citations

Multiple Sclerosis Research Studies

Neonatal Health and Biochemistry

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

Ralf Gold,Ludwig Kappos,et al.

20121,687 citations

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Robert J. Fox,David H. Miller,et al.

20121,322 citations

A Critical Role for Dnmt1 and DNA Methylation in T Cell Development, Function, and Survival

Peggy P. Lee,David Fitzpatrick,et al.

20011,268 citations

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

Manisha Balwani,Eliane Sardh,et al.

2020573 citations

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

Sander F. Garrelfs,Yaacov Frishberg,et al.

2021477 citations

Antigen Presentation Pathways to Class I and Class II MHC‐Restricted T Lymphocytes

T J Braciale,Lynda A. Morrison,et al.

1987322 citations

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

Ronald van Vollenhoven,Paul Emery,et al.

2010284 citations

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

Mathew S. Maurer,Parag Kale,et al.

2023276 citations